SLPI anticorps (Middle Region)
Aperçu rapide pour SLPI anticorps (Middle Region) (ABIN318889)
Antigène
Voir toutes SLPI AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- A 17 amino acid peptide located near the centre of human SLPI.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Western Blot: 1.0 - 2.0g/mL, detects a band of approximately 14 kDa in Daudi cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline containing 0.02 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))
-
Autre désignation
- Antileukoproteinase (ALP)
-
Sujet
- SLPI is a 14kD non-glycosylated protein produced by secretory cells in the respiratory, genital and lacrimal glands, and by macrophages, B-cells and neutrophils. The functions of SLPI are diverse. The SLPI protein inhibits protease activity at sites of inflammation, protecting tissues against protease mediated damage and it possesses anti-microbial/anti-viral activity. In addition, SLPI has been reported to exhibit anti-inflammatory properties, regulating lipopolysaccharide induced activation of NF-kappa beta in peripheral blood monocytes.Synonyms: BLPI, HUSI-1, Mucus proteinase inhibitor, Protease inhibitor WAP4, SLPI, Secretory leukocyte protease inhibitor, Seminal proteinase inhibitor, WAP four-disulfide core domain protein 4, WAP4, WFDC4
-
ID gène
- 9606
-
UniProt
- P03973
Antigène
-